Methotrexate, Mannitol, Rituximab, and Carboplatin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma
Clinical trial NCT00293475 · UNKNOWN
Trial details
- NCT number
- NCT00293475
- Sponsor
- OHSU Knight Cancer Institute
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-14
- Primary completion
- 2022-01-31
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.